VSee Health Stock Forward View - Triple Exponential Smoothing

VSEE Stock   0.28  -0.0018  -0.64%   
Price forecasting for VSee Health requires integrating several analytical layers. This module contributes the sentiment layer - assessing whether investor enthusiasm around VSee Health is driving its price away from fundamental value.
As of now, the 14-period RSI for VSee Health is 0, signaling extreme oversold conditions. Historically, RSI levels this depressed have preceded relief bounces, though the magnitude and duration vary widely.
Momentum
Sell Extended
 
Oversold
 
Overbought
Price forecasting for VSee Health requires integrating several analytical layers. This module contributes the sentiment layer - assessing whether investor enthusiasm around VSee Health is driving its price away from fundamental value. Core fundamental signals used in VSee Health's forecast context:
 EPS Estimate Current Year
-0.03
 EPS Estimate Next Year
-0.36
 Wall Street Target Price
5
 EPS Estimate Current Quarter
-0.09
 Quarterly Revenue Growth
0.187
Hype-based context for VSee Health connects recent headlines with price response and peer activity.
The Triple Exponential Smoothing forecasted value of VSee Health on the next trading day is expected to be 0.27 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 0.91.
VSee Health after-hype prediction price
    
  $ 0.28  
This sentiment layer is designed to be read with forecasting, technical, analyst, earnings, and momentum context.
Use Historical Fundamental Analysis of VSee Health to cross-verify projections for VSee Health. The historical series provides projection context.
To learn how to invest in VSee Stock, please use our How to Invest in VSee Health guide.

VSee Health Additional Predictive Modules

Most predictive techniques to examine VSee price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for VSee using various technical indicators. When you analyze VSee charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Triple exponential smoothing for VSee Health - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When VSee Health prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in VSee Health price movement. However, neither of these exponential smoothing models address any seasonality of VSee Health.

Triple Exponential Smoothing Price Forecast For the 14th of March 2026

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of VSee Health on the next trading day is expected to be 0.27 with a mean absolute deviation of 0.02 , mean absolute percentage error of 0.0004 , and the sum of the absolute errors of 0.91 .
Please note that although there have been many attempts to predict VSee Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that VSee Health's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Stock Forecast Pattern

Backtest VSee Health  VSee Health Price Prediction  Research Analysis  

Forecasted Value

This next-day forecast for VSee Health uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Market Value
0.28
0.0028
Downside
0.27
Expected Value
5.00
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of VSee Health stock data series using in forecasting. Note that when a statistical model is used to represent VSee Health stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0028
MADMean absolute deviation0.0154
MAPEMean absolute percentage error0.0411
SAESum of the absolute errors0.909
As with simple exponential smoothing, in triple exponential smoothing models past VSee Health observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older VSee Health observations.
Mean reversion in VSee Health's price occurs when temporary dislocations - caused by sentiment extremes, news events, or liquidity shocks - correct back toward the stock's historical fair value.
Hype
Prediction
LowEstimatedHigh
0.010.285.00
Details
Intrinsic
Valuation
LowRealHigh
0.071.466.18
Details
1 Analysts
Consensus
LowTargetHigh
4.555.005.55
Details
A rigorous investment case for VSee Health requires more than studying its own financials. Benchmarking VSee Health's performance, valuation, and risk profile against competitors is essential to validate any investment thesis.

After-Hype Price Density Analysis

Understanding VSee Health's probability distribution helps investors calibrate position size to their risk tolerance. The tails of the VSee Health distribution capture low-probability but high-impact outcomes that naive point estimates ignore.
   Next price density   
       Expected price to next headline  

Estimiated After-Hype Price Volatility

Using VSee Health's historical news impact data, we estimate the likely price corridor for the next trading session after a significant headline. VSee Health's after-hype downside and upside margins for the prediction period are 0.01 and 5.00, respectively. Note that past news reactions for VSee Health are not guaranteed to repeat, particularly in novel market environments.
Current Value
0.28
0.28
After-hype Price
5.00
Upside
The after-hype framework applied to VSee Health assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.

Price Outlook Analysis

Have you ever been surprised when a price of a Company such as VSee Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VSee Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with VSee Health, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.75 
4.72
 0.00  
  0.12 
7 Events
6 Events
In 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.28
0.28
0.72 
0.00  
Notes

Hype Timeline

VSee Health is at this time traded for 0.28. The company stock is not elastic to its hype. The average elasticity to hype of competition is -0.12. VSee is forecasted to increase in value after the next headline, with the price projected to jump to 0.28 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is projected to be 0.72%, whereas the daily expected return is at this time at -0.75%. The volatility of related hype on VSee Health is about 2913.58%, with the expected price after the next announcement by competition of 0.16. The company reported previous year's revenue of 10.42 M. Net Loss for the year was -57.7 M with profit before overhead, payroll, taxes, and interest of 7.9 M. Given the investment horizon of 90 days the next forecasted press release will be in 7 days.
Use Historical Fundamental Analysis of VSee Health to cross-verify projections for VSee Health. The historical series provides projection context.
To learn how to invest in VSee Stock, please use our How to Invest in VSee Health guide.

Related Hype Analysis

Understanding how VSee Health's direct competitors react to news events helps investors anticipate contagion effects and sector-wide sentiment shifts that may affect VSee Health's performance.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
HCTIHealthcare Triangle-0.29 10 per month 0.00 -0.59 10.26 -17.61 42.46
ADGMAdagio Medical Holdings-0.01 8 per month 5.41 0.06 9.57 -6.38 64.48
CTXRCitius Pharmaceuticals-0.07 7 per month 0.00 -0.04 10.81 -7.79 30.22
ATHAAthira Pharma-0.60 5 per month 3.97 0.13 9.87 -8.06 72.52
ALURAllurion Technologies 0.08 9 per month 0.00 -0.10 16.55 -22.29 102.34
LPTXLeap Therapeutics 0.01 9 per month 6.90 0.14 25.00 -9.43 65.13
BCTXBriacell Therapeutics Corp-0.03 7 per month 0.00 -0.08 8.72 -8.84 98.43
APLMApollomics Class A-0.72 2 per month 4.27 0.12 10.52 -9.57 29.21
COCHEnvoy Medical-0.09 9 per month 5.47 0.03 10.29 -9.23 90.44
MBRXMoleculin Biotech 0.1 9 per month 0.00 -0.18 7.73 -10.18 56.02

Other Forecasting Options for VSee Health

The price movement of VSee is a central concern for all potential investors, regardless of their level of expertise. VSee Stock price charts can be difficult to interpret due to the noise present in the data.

VSee Health Related Equities

The following equities are related to VSee Health within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing VSee Health against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
 Risk & Return  Correlation

VSee Health Market Strength Events

Market strength indicators applied to VSee Health stock help investors assess the relative momentum and resilience of the security in different market environments. By using these indicators, traders can make more informed decisions about when to buy or sell VSee Health.

VSee Health Risk Indicators

Risk indicator analysis for VSee Health is essential for accurately projecting its future price trajectory. By identifying the level of risk embedded in VSee Health's investment, investors can make informed decisions about position sizing and risk mitigation.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Story Coverage note for VSee Health

Coverage intensity for VSee Health matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.

VSee Health Short Properties

Short sentiment tied to VSee Health matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
Common Stock Shares Outstanding10.2 M
Cash And Short Term Investments326.1 K

More Resources for VSee Stock Analysis

A structured review of VSee Health often starts with core financial statements and trend context. Ratios and trend metrics help frame VSee Health's operating context. Key reports that frame VSee Health Stock are listed below:
Use Historical Fundamental Analysis of VSee Health to cross-verify projections for VSee Health. The historical series provides projection context.
To learn how to invest in VSee Stock, please use our How to Invest in VSee Health guide.
Analysis related to VSee Health should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
 Earnings Share
0.46
 Revenue Per Share
0.887
 Quarterly Revenue Growth
0.187
 Return On Assets
-0.26
 Return On Equity
-2.60
The market value of VSee Health is measured differently than book value, which reflects VSee accounting equity. VSee Health's market capitalization is 12.5 M. With a P/B ratio of 3.63, the market values VSee Health well above its book equity. Enterprise value stands at 21.77 M. Value and price for VSee Health are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that VSee Health's intrinsic value and market price are different measures derived from different inputs. For VSee Health, key inputs include a P/B ratio of 3.63, a profit margin of -69.81%, ROE of -2.6%, and revenue of 10.42 M. Market price reflects the current exchange level formed by active bids and offers.